RSS Search

 News  Feeds  Images  Tags  Search Shortcuts

Feedsfarm.com > Feeds > Market Wire - Pharmaceuticals and Biotech > Archive

Market Wire - Pharmaceuticals and Biotech News Archive

Market Wire - Pharmaceuticals and Biotech

http://img.marketwire.com/rss/mwPharmaceuticalsBiotech.rss

Page: 1 of 21 Market Wire - Pharmaceuticals and Biotech

  1. CancerVax: CancerVax to Webcast Corporate Presentation at Thomas Weisel Healthcare Tailwinds 2005 Conference
  2. Theravance, Inc.: Theravance to Present at Thomas Weisel Partners' Healthcare Conference 2005
  3. Immusol, Inc.: Immusol, Inc. Announces Research Collaboration With Peking University to Develop Therapeuic Compounds
  4. Takeda Pharmaceuticals North America, Inc.: ACTOplus met(TM) (pioglitazone HCl and metformin HCl) Approved by the FDA for Type 2 Diabetes
  5. Acambis PLC: Acambis Plc announces its Results for the Second Quarter and Six Months Ended 30 June 2005
  6. BIOLASE Technology, Inc.: BIOLASE Announces 510k FDA Submission of Its OCULASE MD(TM) for Ophthalmology
  7. bioalma: EMBL and bioalma Sign Agreement to License almaKnowledgeServer (AKS) as Part of Joint Research Project
  8. Amexdrug Corporation: Amexdrug Corporation Announces Settlement of Litigation and Other Matters
  9. Smith & Nephew PLC: Smith and Nephew PLC announce Investor Visit
  10. XTL Biopharmaceuticals Ltd: XTL Biopharmaceuticals Ltd announces Interim Results for the Six Months Ended 30 June 2005
  11. Trinity Biotech: Trinity Biotech Directors Purchase Shares in the Company
  12. CancerVax: CancerVax to Webcast Corporate Presentation at Bear Stearns 18th Annual Healthcare Conference
  13. NeuroInvestment: Insomnia Programs Reviewed by NeuroInvestment
  14. Healtheuniverse: Healtheuniverse Establishes the Institute of Healtheliving to Further Research and Commercialization of Regenerative Cell Technologies
  15. AlphaRx Inc.: AlphaRx Provides Update on Phase II Trial of Indaflex(TM) for the Treatment of Osteoarthritis of the Knee
  16. ISOA: New Study Finds Health Care Costs Associated With Vascular Dementia Are Higher Than Alzheimer's Disease
  17. HomelandDefense, Inc.: Upcoming HomelandDefenseStocks.com Homeland Security Online Conference Sept 21, 2005 Adds Keynote Speaker Jim Smith, Homeland Defense Business Correspondent for Jane's Defence Weekly, MSNBC, BBC, and CNN
  18. Trestle Holdings, Inc.: Trestle Receives Notice of Allowance for U.S. Patent on Region of Interest Detection for Digital Slide Scanning
  19. Datascope Corp.: Datascope Declares Cash Dividend
  20. Cell Bio-Systems: Cell Bio-Systems, Inc.(R) Unveils New Line of Tulip(R) Disposable Plastic Surgery Instruments at Plastic Surgery 2005 Show
  21. Theravance, Inc.: Theravance to Present at Global Pharmaceutical, Biotech & Medtech Conference
  22. Cyclacel Group PLC: Cyclacel Group PLC announces Collaboration on Nephrology Applications of CDK Inhibitors
  23. Smith & Nephew PLC: SMITH AND NEPHEW PLC ANNOUNCES CHANGE TO INVESTOR VISIT
  24. Healtheuniverse: Healtheuniverse Announces Intellectual Property Development Utilizing Fat Cells to Regenerate Stem Cells
  25. Polydex Pharmaceuticals Limited: Polydex Pharmaceuticals Reports Second Quarter Results
  26. ICTI: ICTI Expert Hosts Roundtable at FDA Conference
  27. Provalis PLC: Provalis PLC announces Notice of Results
  28. International Disease Management Alliance: IDMA (International Disease Management Alliance) Announces the Launch of Its Bi-Monthly Web-Cast Lecture Series on Disease Management
  29. Centocor: FDA Approves Remicade(R) as First and Only Biologic to Treat Ulcerative Colitis
  30. SciClone Pharmaceuticals, Inc.: SciClone Pharmaceuticals to Present at UBS Global Life Sciences Conference
  31. Leerink Swann & Company: Leerink Swann & Company Initiates Coverage of Coley Pharmaceutical Group, Inc. (NASDAQ: COLY)
  32. Evolutec Group PLC: Evolutec Group Plc announces Positive Phase II Clinical Result for rEV131 In Seasonal Allergic RHiNITIS (Hay Fever)
  33. Oxford Biomedica Plc: Oxford Biomedica Plc announces Interim Results
  34. Communications Four: Diabetes Awareness Campaign -- Diabetes 'Aware and Care' Event Helps Those With Diabetes Receive the Tools and Education to Help Manage Their Condition
  35. AlphaRx Inc.: AlphaRx Completes Formulation Development of Vansolin(TM), a Novel Vancomycin Formulation in Nanoparticles Intended to Treat Life-Threatening Infectious Disease
  36. Celtic Pharma: Celtic Pharma Acquires Worldwide Rights
  37. Fast Track Systems: Fast Track Announces New CEO, Key Customer Agreements
  38. AlphaRx Inc.: AlphaRx Completes Development of Vansolin(TM), a Vancomycin Incorporating the Company's Proprietary Nanoparticle Delivery Platform, Indicated in the Treatment of Life Threatening Infectious Diseases
  39. GPC Biotech AG: GPC Biotech to Present at UBS Global Life Sciences Conference in New York City
  40. Vitro Diagnostics, Inc.: Vitro Signs Letter of Intent to Form Strategic Alliance With European Biotechnology Firm
  41. AMCP: AMCP Salutes Medicare Milestone
  42. Protherics Plc: Protherics PLC announces Additional Listing
  43. The BioBalance Corp: New York Health Care, Inc. Announces Listing on the OTC Bulletin Board
  44. Amarillo Biosciences, Inc. : Amarillo Biosciences to Provide Oral Interferon for MD Anderson Clinical Trial in Patients With Bone Marrow Disorders
  45. Amazon Biotech, Inc: Amazon Biotech, Inc. Announces Appointment of Dr. Arthur Englard as Scientific Director
  46. BioProgress PLC: BioProgress Plc announces Notification of Interest
  47. Biocompare, Inc.: "Shopping Around" in the Antibody Market
  48. Cryotech / VBS International: Patented, Specialty Liquid Nitrogen Dosing Option With Low Pressure Dose for Wide Mouth Containers With Openings of 38mm or Wider
  49. BioProgress PLC: BioProgress PLC - Interim Results
  50. SciClone Pharmaceuticals, Inc.: SciClone to Report Top-Line Data From First U.S. Hepatitis C Phase 3 Trial by Mid-December 2005
  51. WireWorks West: Biopharmaceutical Laboratory Process Control & Data Management Software -- FermWorks 2.2 -- Saves 30% of Development Time
  52. Protherics Plc: PROTHERICS PLC ANNOUNCES - COMMENCE TRADING ON NASDAQ
  53. Freedonia Group: World Caps & Closures Demand to Reach Nearly $26 Billion in 2009
  54. Threshold Pharmaceuticals: Threshold Files Registration Statement for Follow-On Offering
  55. Eisai Inc.: Eisai Announces Exclusive In-License of All U.S. Promotional Rights for Fragmin(R), an Injectable Anti-Clotting Agent
  56. Eisai Co., Ltd.: Eisai Signs In-Licensing Agreement With Dainippon Pharmaceutical for Potential New Treatment for Diabetic Neuropathy
  57. Amarillo Biosciences, Inc.: Amarillo Biosciences Issues Progress Report
  58. Leerink Swann & Company: Leerink Swann & Company Initiates Coverage of Forest Laboratories, Inc. (NYSE: FRX)
  59. Eisai Co., Ltd.: Reminder - Eisai Signs In-Licensing Agreement With Dainippon Pharmaceutical for Potential New Treatment for Diabetic Neuropathy
  60. Eden Bioscience Corporation: Eden Bioscience Applies to Transfer Its Stock Listing to The Nasdaq Capital Market
  61. Pinnacle Group Unlimited Inc.: Pinnacle Group Unlimited, Inc. Retains Corporate Auditors
  62. BioProgress PLC: BioProgress PLC announces Interest in Shares
  63. The BioBalance Corporation: The BioBalance Corporation Announces New Management Position
  64. Acambis PLC: Acambis PLC - Proposal to the DHHS
  65. Phoenix Law Group: Pharmaceutical Strategies Group Selects Phoenix Law Group as Law Firm of Record
  66. NeuroInvestment: Neurogenesis Programs Reviewed by NeuroInvestment
  67. WelChol: New Study Finds Additional LDL-C Drops When WelChol(R) (colesevelam HCl) Is Added to Fenofibrate in Patients With Mixed Hyperlipidemia
  68. Oxford Biomedica Plc: Oxford Biomedica Plc announces Prelim Phase II Results
  69. AVL Global, Inc.: AVL Global Signs Merger Documents
  70. WayPoint Biomedical, Inc.: WayPoint Completes Agreement With Euro American Marketing & Sales to Distribute WayPoint's Drink Detective(TM) Product Range Into the US Over the Counter Retail Sector
  71. ALR Technologies Inc.: Respiratory Compliance Solutions Announces Agreements to Offer Respiratory Patients EVO Medical Solutions' Aeroneb Go MicroPump Nebulizer and ALR Technologies' Nebulizer Compliance Monitoring System
  72. Protherics Plc: Protherics PLC announces Block Listing
  73. slp3D: OR-Live.com Presents: Live Internet Broadcast of CyberKnife Spine Radiosurgery to Be Hosted at Atlantic Health's Overlook Hospital
  74. Protherics Plc: PROTHERICS PLC ANNOUNCES NOTIFICATION OF MAJOR INTERESTS IN SHARES
  75. Protherics Plc: Protherics plc announces interests in shares
  76. StarInvest Group, Inc.: StarInvest Portfolio Company New Life Scientific Establishes Three Business Units
  77. Xpention Genetics, Inc.: Xpention Genetics Signs Research Agreement With Colorado State University
  78. Cincom: Cincom Cuts Zagreb Insurance Report Production Time From 2 Days to 45 Minutes
  79. SciClone Pharmaceuticals, Inc.: SciClone Names Israel Rios, M.D. as Chief Medical Officer
  80. Symbollon Pharmaceuticals, Inc.: Symbollon Pharmaceuticals, Inc. Announces Strategic Alliance With Premier Funding and Financial Marketing Services of Mesa, Arizona
  81. ER Urgent Care Centers: ER Urgent Care Centers Is Proud to Announce Grand Opening of Kansas City
  82. BSD Medical Corp.: BSD Medical Focuses on New Breakthroughs in Treating Breast and Cervical Cancer for Largest US Radiation Conference
  83. AlphaRx Inc.: AlphaRx to Accelerate Indaflex(TM) Phase II Trial
  84. Cyclone Commerce: Astellas Pharma US, Inc. Chooses Cyclone Commerce to Enable Secure, Visible Supply Chain
  85. Ezcomm Enterprises, Inc.: Ezcomm Enterprises, Inc. Announces Completion of Exchange Transaction With Eugene Science, Inc.
  86. Theravance, Inc.: Theravance to Report Third Quarter 2005 Financial Results on October 27, 2005
  87. In Veritas Medical Diagnostics Inc.: In Veritas Exhibit at Healthcare Technologies Showcase
  88. Pinnacle Group Unlimited Inc.: Pinnacle Group Unlimited Inc. Completes Acquisition of Bioplus Pharma
  89. HEALTHPOINT, Ltd.: Hammond Joins HEALTHPOINT(R) as Director of Business Operations
  90. Barrier Therapeutics, Inc.: Barrier Therapeutics to Make Eight Scientific Presentations at the 14th European Academy of Dermatology and Venereology Congress
  91. Amnis Corporation: Amnis Corporation Receives Issuance of Three Strategic Patents From the US Patent and Trademark Office
  92. SciClone Pharmaceuticals, Inc.: SciClone Pharmaceuticals to Present at Biotechnology Industry Organization (BIO) Investor Forum
  93. Leerink Swann & Co.: Leerink Swann & Company Initiates Coverage of MannKind Corporation (NASDAQ: MNKD)
  94. Barrier Therapeutics, Inc.: Barrier Therapeutics Submission for Zimycan(TM) Deemed a Complete Response by FDA
  95. Leerink Swann & Company: Leerink Swann & Company Initiates Coverage of Endo Pharmaceuticals Holdings, Inc. (Nasdaq: ENDP)
  96. DNAPrint genomics, Inc.: DNAPrint genomics Forms Pharmaceutical Subsidiary
  97. Oxford Biomedica Plc: Oxford Biomedica Plc announces Oxford BioMedica presents encouraging final phase II results with Trovax(R) in colorectal cancer at the international colorectal cancer congress
  98. QUMAS: QUMAS and LORENZ Partner to Provide Integrated Document Submission and Compliance Solution for Life Sciences Firms
  99. Leerink Swann & Co.: Leerink Swann & Company Initiates Coverage of Panacos Pharmaceuticals, Inc. (NASDAQ: PANC)
  100. Protherics Plc: Protherics Plc announces Holding(s) in Company